1.Study on the construction of policy system for the application of appropriate health technologies in rural areas
Jianmin JIANG ; Wei ZHU ; Zhijun XIA ; Jie SHEN ; Xin WEN
Chinese Journal of Medical Science Research Management 2012;25(3):175-178
To enhance the capacity for extending and applying appropriate health technologies in rural areas in China,this paper proposes a supportive policy system that incoperates macro,average and microlevels. Thepolicysystemfocusesonorientation, incentives, regulationsand standardization,and its objectives and measures of each level are described.The policy system will contribute to the sustainable development rural health work.
2.Posttransplant bone metastasis in hepatocellular carcinoma patients receiving liver transplantation
Zhao LI ; Jie GAO ; Xin SUN ; Guangming LI ; Jiye ZHU
Chinese Journal of General Surgery 2013;(3):193-195
Objective To analyze clinical features,surgical treatment efficacy and prognostic factors of bone metastasis patients after liver transplantation for hepatocellular carcinoma.Methods A retrospective clinical data of 20 bone metastasis patients after liver transplantation for hepatocellular carcinoma from July 2000 to January 2010 were received.The effect of surgery aimed at bone metastasis was evaluated.Univariate and multivariate prognostic risk factors were analyzed.Results The median survival time of these patients was 7.5 months and 1-year survival rate was only 20%.Surgical treatment could relieve pain and promote patients' peformance status significantly.Univariate and multivariate analysis found that tumor microvascular invasion within the removed recipient liver was the only prognostic risk factor.Conclusions Patients of bone metastasis after liver transplantation for HCC had poor prognosis.Surgical treatment helps improve patient's quality of life.Tumor microvascular invasion is the risk factor of surgical prognosis.
3.The influence of carnosine in expression levels of bcl-2 and bax after focal cerebral ischemia in rats
Jie ZHU ; Qian MA ; Xin WANG ; Cuimei LIU ; Aihong WANG
Tianjin Medical Journal 2015;(3):259-262
Objective To explore the effect of carnosine in the expression of B cell lymphomal/leukemia-2 (bcl-2) and bcl-2-associated X protein (bax) after focal cerebral ischemia in rats. Methods Thirty male SD rats (SPF scale) were ran?domly divided into 3 groups:sham-operated group, model group and carnosine treated group (n=10 for each group). The mid?dle cerebral artery occlusion model (MCAO) was induced in model group and carnosine treated group. Rats were received carnosine [1 000 mg/(kg·d), orally] in carnosine treated group, and the other rats were received the same volume of normal sa?line (NS) in shame-operated group and model group. The neurological deficit score was used to evaluate the neurological function at 24 h and 72 h after MCAO. Morphological changes were observed by HE staining. TCC staining was used to label infarct volume, and immunohistochemistry was used to detect the expression of bcl-2 and bax. Results Compared with model group, the score of neurological function and infarct volume were significantly declined in carnosine treated group at 72 h after injury (P<0.05 or P<0.01). The changes of ischemic impairment were lighter in carnosine treated group than that of model group. Compared with sham-operated group, the expression levels of bcl-2 and the ratio of bcl-2/bax were de?creased while the expression of bax was increased in model group (P<0.05). Compared with model group, carnosine could sig?nificantly increase the expression of bcl-2 and the ratio of bcl-2/bax, and reduce the expression of bax (P<0.01 or P<0.05). Conclusion Carnosine can enhance bcl-2 expression, decrease bax expression and increase the ratio of bcl-2/bax, which is likely to be one of the mechanisms of neuroprotection.
4.Progress in application of ultrasound guided three-dimensional printing on the assessment of structural heart disease
Yanbo ZHU ; Jie GENG ; Xin GUAN ; Jianshi LIU
Tianjin Medical Journal 2016;44(8):974-977
Structural heart disease includes congenital cardiovascular structural abnormalities, valvular heart disease and cardiomyopathy, which shows the common features of cardiac anatomical structure and hemodynamic abnormalities, especially anatomical abnormalities. Echocardiography, especially three-dimensional (3D) ultrasound, is good at displaying anatomical structure and blood flow abnormalities. As a non-invasive method of examination, it has advantage in the evaluation of such heart diseases. In recent years, the gradual rise of 3D printing technology can make physical printing, and the printed heart model can stereoscopically display abnormal state of heart diseases. Ultrasound combined with 3D printing technology may provide more intuitive and accurate information for the assessment of structural heart disease.
5.Progress of motor relearning programme on the functional recovery of patients after stroke
Qian MA ; Xin WANG ; Jie ZHU ; Aihong WANG
Chinese Journal of Practical Nursing 2015;31(27):2103-2106
Dysfunction after stroke caused great burden to patients,families and society,early rehabilitation training is an effective and economic way to improve the function.Motor relearning program (MRP) is a popular rehabilitation method in recent years.In this reviw,the concept and characteristics of MRP are introduced firstly,then we summarize three elements in implementation of MRP,including time,strength and environment,and finally,the application of MRP in clinical stroke patients is emphasized.
6.Herb-herb interaction in traditional Chinese medicine:a review of pharmacokinetics-based interaction in Herb-Pairs
QIANG WEI-JIE ; CHEN YING ; ZHAO ZHENG ; YIN JIE ; ZHU XIAO-XIN
Chinese Journal of Pharmacology and Toxicology 2017;31(10):996-996
″Herb-Pairs″, also known as pair drugs, refers to a prescription consisted of two relatively fixed traditional Chinese medicine, is the most basic, most simple and most common form of medication prescription in traditional Chinese medicine compound compatibility. It is not a random combination of two herbs, nor is the simple accumulation of efficacy, but the simple and delicate experience of ancient Chinese medicine practitioners. As a bridge between single drug and prescriptions, it is the embodiment of the regular and dialectical connotation. Therefore, research on Herb-Pairs has always been the most basic and most important entry point for compound compatibility studies. However, the interaction between herbs and herbs is an effect with a downside as well as benefits. The beneficial herb-herb interaction in Herb-Pairs include mutual promotion, mutual enhancement, mutual restraint between two drugs and counteract toxicity of another drug. And the harmful herb- herb interaction in Herb- Pairs includes mutual inhibition and antagonism. All of these interactions areby means of affecting the metabolism of components to play a therapeutic effect. Using the pharmacokinetic-pharmacodynamic (PK-PD) binding model, the combination of drug metabolism and pharmacodynamics can further elucidate the influence on effect caused by drug concentration and metabolism, which can help elucidate the mechanism of drug action. Consequently, in this review, the herb-herb interactions in terms of pharmacokinetic were summarized to elucidate rule of TCM compatibility.
7.Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy
Xin LI ; Hang ZHU ; Peng LI ; Qian XIN ; Jie LIU ; Wei ZHANG ; Youhong XING ; Hao XUE
Journal of Geriatric Cardiology 2013;(3):286-290
Background Serum cystatin C levels can be used to predict morbidity and mortality in patients with cardiovascular disease. However, the clinical relevance of serum cystatin C levels in patients with hypertensive left ventricular hypertrophy (LVH) has rarely been investigated. We designed the present study to investigate whether serum cystatin C levels are associated with cardiac structural and functional alterations in hypertensive patients. Methods We enrolled 823 hypertensive patients and classified them into two groups:those with LVH (n=287) and those without LVH (n=536). All patients underwent echocardiography and serum cystatin C testing. We analyzed the relationship be-tween serum cystatin C levels and LVH. Results Serum cystatin C levels were higher in hypertensive patients with LVH than in those without LVH (P<0.05). Using linear correlation analysis, we found a positive correlation between serum cystatin C levels and interven-tricular septal thickness (r=0.247, P<0.01), posterior wall thickness (r=0.216, P<0.01), and left ventricular weight index (r=0.347, P<0.01). When analyzed by multiple linear regression, the positive correlations remained between serum cystatin C and interventricular septal thickness (β=0.167, P<0.05), posterior wall thickness (β=0.187, P<0.05), and left ventricular weight index (β=0.245, P<0.01). Con-clusion Serum cystatin C concentration is an independent marker for hypertensive LVH.
8.Primary osteosarcoma of ureter: report of a case.
Xin-mu ZHOU ; Xin-qing YE ; Yi-ling ZHU ; Hong-ming SUN ; Jie CHEN ; Shao-jie XU
Chinese Journal of Pathology 2010;39(2):117-118
12E7 Antigen
;
Aged
;
Antigens, CD
;
metabolism
;
Carcinoma, Transitional Cell
;
pathology
;
Carcinosarcoma
;
pathology
;
Cell Adhesion Molecules
;
metabolism
;
Cystectomy
;
methods
;
Diagnosis, Differential
;
Follow-Up Studies
;
Humans
;
Male
;
Nephrectomy
;
Osteosarcoma
;
metabolism
;
pathology
;
surgery
;
Ureter
;
surgery
;
Ureteral Neoplasms
;
metabolism
;
pathology
;
surgery
;
Vimentin
;
metabolism
9.Molecular evolution of HA1 in pandemic H1N1 influenza viruses isolated in Guangdong during 2009 to 2011
Xin ZHANG ; Hanzhong NI ; Dawei GUAN ; Lirong ZOU ; Jie ZHOU ; Nianmei HOU ; Xiaolan ZHU ; Hong XIAO ; Changwen KE ; Jie WU
Chinese Journal of Microbiology and Immunology 2011;31(8):735-739
Objective To understand the evolutionary characterization of hemagglutinin (HA)gene of pandemic H1N1 influenza virus in Guangdong during 2009-2011. MethodsWe selected 83 pandemic H1N1 strains isolated in Guangdong during 2009-2011. The HA1 genes were sequenced and analyzed comparatively by Bioedit 7.0 and MEGA 4.0. ResultsThe evolutionary rate of Hal gene of pandemic H1N1 and seasonal H1N1 viruses was 5.2×10-3 substitutions/site/year, higher than that of seasonal H1N1 viruses. Most amino acid changes in HA1 molecules accumulated on the surface of the molecule and were partly located in antigenic sites. Two fatal infections were detected with a mutation at HA residue 222, in one virus with a change D222G, and in one virus D222N. ConclusionThe phylogenetic analysis demonstrates that the influenza epidemic in Guangdong at the beginning of 2011 are due to occurrence of genetic changes of pandemic H1N1 virus. The amino acid change at residue 222 of the HA1 are likely to be associated with severe or even fatal illness.
10.Advances on pharmacokinetics of traditional Chinese medicine under disease states.
Zi-peng GONG ; Ying CHEN ; Rui-jie ZHANG ; Qing YANG ; Xiao-xin ZHU
China Journal of Chinese Materia Medica 2015;40(2):169-173
In recent years, more and more research shows that the pharmacokinetic parameter of traditional Chinese medicine can be affected by the disease states. It's possible that drug metabolic enzymes, transporters, cell membrane permeability and the change of microbes group could be interfered with physiological and pathological changes, which enables the pharmacokinetics of traditional Chinese medicine in the body to be altered, including the process of absorption, distribution, metabolism and excretion, and then the pharmacokinetic parameters of traditional chinese medicine are altered. It's found that investigating the pharmacokinetic of traditional Chinese medicine in the pathological state is more useful than that of in normal state because the great part of traditional Chinese medicine is mainly used to treat disease. This article reflects the latest research on the pharmacokinetic of traditional Chinese medicine in the disease state such as diabete, cerebral ischemia, liver injury, inflammatory disease, nervous system disorders and fever in order to provide certain reference for clinicians designing reasonable administration dose.
Animals
;
Brain Ischemia
;
drug therapy
;
Chemical and Drug Induced Liver Injury
;
drug therapy
;
Humans
;
Inflammation
;
drug therapy
;
Medicine, Chinese Traditional
;
Nervous System Diseases
;
drug therapy